BioCentury
ARTICLE | Clinical News

Influenza DNA vaccine: Completed Phase I enrollment

June 30, 2008 7:00 AM UTC

Vical completed enrollment of 100 patients in a double-blind, placebo-controlled, U.S. Phase I trial evaluating Vaxfectin-formulated DNA vaccine, delivered via syringe or the Biojector 2000 jet injec...